TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | -1 | -3 | 15 | -1 | 16 | -24 | 0 |
| P | %wins | 0 | 0 | 100 | 50 | 50 | 0 | 33 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/15/05 11:19 | 3/11/05 | NPSP | Nps Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Clark David L | UT | O | VP,Corpo | P | 60 | 10.97 | 10 | 6 | 171 | 9 | D | -25 | -57 | -46 | -32 | -28 | -18 | -16 | 5 | -1 | -1 | 13 | -10 | -5 | -23 |
8/4/03 17:13 | 7/31/03 | NPSP | Nps Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Clark David L | UT | O | VP,Opera | P.a | 5 | 17.48 | 11 | 0 | 10 | 3 | D | -8 | 23 | 13 | 28 | -2 | -2 | -1 | 1 | -1 | -5 | 17 | 8 | 37 | -25 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |